Call for Abstracts

The EAACI Scientific Programme Committee and the Local Organising Committee welcome the submission of original contributions for oral and poster presentation at the Congress. Only abstracts not published elsewhere or submitted for presentation at another national and/or international meeting will be considered for presentation.

Abstracts received after this date will not be considered.

The presenting author must register for the congress and pay the registration fee when submitting the abstract, otherwise the abstract will not be reviewed. If the abstract is not accepted the registration fee is refundable.

Carefully read the guidelines in this announcement and the guidelines on the submission start page before submitting your abstract. Acknowledgement of receipt of your submission will be returned to your email address immediately upon submission.
If you do not receive the e-mail, your submission was not completed and your abstract needs to be re-submitted.

Please observe that this year abstracts can only be submitted electronically. Extended deadline for abstract submission is 14 February 2003. Abstracts must be written in English and the presentations must be in English. Accepted abstracts selected by expert reviewers will be presented in oral and poster sessions. Poster presenters will be asked to be present by their poster during a poster session. Authors should indicate in the space provided the preferred method of presentation.
In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study, the method used, the result observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You may subtitle the paragraphs in bold format in the following order: Background, Method, Results, and Conclusion.
The abstract title and body text should only include pharmacopeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required at the first place a drug is mentioned. References, credits or the authors’ academic degrees or grant support must not be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text.
It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar, or scientific fact will be reproduced as typed by the author.
Please note that each year a number of abstracts are rejected because they contain no data or the English is unacceptable. Changes to abstracts can only be accepted until the deadline using the Personal Page. From the Congress web site you can access to your Personal Page by using your password included in the e-mail received upon submission.

One of the following topics that best describes the abstract should be indicated upon submission:
  • Asthma
  • Dermatological allergy
  • Urticaria
  • Rhinitis
  • Mechanisms of allergy
  • IgE biology
  • Inflammatory cells & mediators
  • Autoimmunity
  • Immunodeficiencies
  • Epidemiology
  • Paediatric asthma
  • Paediatric allergies
  • Risk factors for allergy
  • Food allergy
  • Drug allergy
  • Immunotherapy
  • Occupational allergy & asthma
  • Insect hypersensitivity
  • Allergy diagnosis
  • Ocular allergy
  • Allergy & sports
  • Infection & allergy
  • Pollution & environment
  • Aerobiology & allergens
  • Patient education
  • Clinical services
  • Training and education

Notification of acceptance/rejection will be e-mailed in mid March (contact Congrex if you have not received your notification email by the beginning of April). The corresponding author will receive all correspondence concerning the abstract.
The corresponding author is responsible for informing all authors of the status of the abstract.

Accepted abstracts will be published in the Abstract Book, a supplement of Allergy, the European Journal of Allergy and Clinical Immunology, which will be given to all delegates attending the Congress upon registration in Paris. Accepted abstracts will also be published on a CD-ROM and/or on the Internet.

For submission support please contact the Congress secretariat at